Disclaimer: You are now leaving www.HIVReagentProgram.org and are going to a website that is not operated by NIH HIV Reagent Program. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE:
NIH HIV Reagent Program offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links, you will leave the NIH HIV Reagent Program website and will be redirected to another site. These sites are not under the control of NIH HIV Reagent Program.
NIH HIV Reagent Program is not responsible for the content of linked third party websites. We are neither an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information.
Please read third party privacy and security policies closely as these may be different than NIH HIV Reagent Program policies.
If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
Quantity limit per order
for this item is 1. This item can be ordered twice a year. Orders over this
limit will be sent to NIAID for approval before shipment.
Antibody Class: IgG1λ
ARP-11710 is aCD4i with hexa-histidine and FLAG
tags monoclonal antibody to
human immunodeficiency virus 1 (HIV-1) against gp120 (2442) produced by Escherichia
coli, strain HB2151 cells.
Note: ARP-11710 may be stored at 4°C for short-term
storage and at -80°C for long term storage. Avoid freeze-thaw cycles as reagent
degradation may result.
Each vial of ARP-11710 contains approximately
100 µg purified antibody at 1.91 µg
per µL in PBS. Please refer to the appropriate data sheet for
Dimitrov et. al., United States Patent Applications US 2004/0259075 A1 and US 2007/0212349 A1; Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By Env-Cd4-Co-Receptor Complexes.
Zhang, M. Y., et
al. “Improved Breadth and Potency of an
HIV-1 Neutralizing Single-Chain Antibody by Random Mutagenesis and Sequential Antigen
Panning.” J. Mol. Biol. 335 (2004): 209-219. PubMed:
When applying for permits and forms please:
Do NOT reference NIH HIV Reagent Program or ATCC Catalog Numbers in the Material Description
fields found on the permits and/or forms.
Make sure your name and address on the permit applications and/or forms are exactly
as they appear on your NIH HIV Reagent Program registration.
Information about permits is provided as a courtesy to NIH HIV Reagent Program customers.
While we use reasonable efforts to include accurate and up-to-date information on
this page, we make no warranties or representation as to its accuracy.
For more information on the necessary compliance requirements associated with the
biological materials provided by NIH HIV Reagent Program, please select this link: Compliance Requirements.
Knowledge Base (FAQs)
Microsoft PowerPoint Viewer
Microsoft Word Viewer
Microsoft Excel Viewer
Call Us Toll-Free:+1 (888) 487-0727
TTY: (703) 365 - 2727